z-logo
Premium
Dose proportionality of amrinone
Author(s) -
Edelson Jerome,
Park George B,
Angellotti Jon,
Kershner Ronald P,
Ryan Jerome J,
McMahon F Gilbert
Publication year - 1983
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1983.151
Subject(s) - clinical pharmacology , crossover study , chemistry , plasma concentration , amrinone , pharmacology , mathematics , medicine , inotrope , placebo , alternative medicine , pathology
Arminone was given to 18 healthy subjects in doses of 75, 150, and 225 mg in a randomized crossover design. Plasma levels were shown to rise in proportion to dose. The mean plasma AUC, extrapolated to infinite time, was determined for each dose level; the values obtained were 4, 8.18, and 12.35 μg · hr/ml for the 75‐, 150‐, and 225‐mg doses. Mean maximum observed plasma concentrations were 1.03, 1.74, and 2.58 μg/ml. At higher doses the extrapolated AUC is more variable, but it is linear over the range of 0.73 to 3.81 mg/kg. The apparent first‐order terminal elimination rate is not dose dependent and corresponds to a t½ of 3.85 hr. Clinical Pharmacology and Therapeutics (1983) 34 , 190–194; doi: 10.1038/clpt.1983.151

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom